Screening for Lung Cancer: An Expert Review
Lung cancer screening has been shown to be an effective tool in decreasing lung cancer-related mortality and is recommended by several organizations, including NCCN. However, overall use of appropriate screening for high-risk patients remains low. Provider education may increase screening utilization and improve patient outcomes for those living with lung cancer.
Category
  • Lung Cancers
Format
  • Recorded Webcast
Credits
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 Participation
NCCN Guidelines® Update: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
The use of BTKi and BCL-2 inhibitors as a preferred treatment approach for treatment-naive chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) has significantly transformed the treatment landscape of relapsed/refractory disease.
Category
  • Chronic Lymphocytic Leukemia
Format
  • Recorded Webcast
Credits
  • 0.75 AAPA Category 1 CME credit
  • 0.75 ACPE contact hours
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 ANCC contact hours
  • 0.75 Participation
Updates in the Systemic Therapy Options for Clear and Non-Clear Cell Renal Cell Carcinoma
The expansion of treatment options included in the treatment guidelines has certainly improved outcomes of patients with advanced RCC but presents numerous clinical challenges, such as determining best choice of primary treatment for a given patient based on tumor biology and clinical characteristics and in choosing appropriate subsequent lines of treatment.
Category
  • Kidney Cancer
Format
  • Recorded Webcast
Credits
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 Participation
Plenary Session: Best Practices for Addressing the Health Needs of the LGBTQ+ Community in Oncology Care
In 2022, NCCN conducted a patient advocacy scan with roughly a dozen representatives from the LGBTQ+ community representing patient advocates, researchers, and healthcare providers with expertise in this area. The results of the scan found that patients who are LGBTQ+ are likely to report experiencing bias and discrimination in care which can impact their care outcomes.
Category
  • Supportive Care Topics
Format
  • Recorded Webcast
Credits
  • 1.50 AAPA Category 1 CME credit
  • 1.50 ACPE contact hours
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 ANCC contact hours
  • 1.50 ASWB continuing education credit
  • 1.50 Participation
Sexual Identity and Function in Patients with Cancer and Survivors
Many cancer survivors of all gender identities and sexual orientations experience survivorship challenges, including challenges regarding sexual function. These concerns are often not addressed appropriately, especially in those who identify as sexual and gender minorities. Healthcare providers should be aware of the challenges experienced by all cancer survivors to better assist them in their survivorship journey.
Category
  • Supportive Care Topics
  • Survivorship
Format
  • Recorded Webcast
Credits
  • 1.50 AAPA Category 1 CME credit
  • 1.50 ACPE contact hours
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 ANCC contact hours
  • 1.50 ASWB continuing education credit
  • 1.50 Participation
The Implementation Science of Patient Reported Outcomes
Challenges persist in patient reported outcomes (PRO) visualization, achieved through thoughtful workflows and electronic health record integration. The value of PROs to the patient and provider is dependent on data that is accessible, meaningful, and actionable.
Category
Format
  • Recorded Webcast
Credits
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 Participation
Cancer Screening in Underrepresented Populations
All individuals, regardless of their race, socioeconomic status, or gender identity deserve the best chance at beating cancer.
Category
Format
  • Recorded Webcast
Credits
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 ASWB continuing education credit
  • 1.00 Participation
Mobile Screening Programs: Improving Patient Access to Oncology Care
It is important for cancer centers that are interested in developing mobile screening programs at their respective institutions to be informed about issues and challenges experienced in the development of successful mobile screening programs.
Category
Format
  • Recorded Webcast
Credits
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 Participation
Targeted Therapy for Metastatic Non-Small Cell Lung Cancer
Clinicians need to be aware of the most recent recommendations about biomarker testing and the appropriate use of new targeted therapies (including sequencing these therapies, assessing and managing side effects from these therapies), so they can select the most appropriate therapy for their patients with metastatic NSCLC.
Category
  • Lung Cancers
Format
  • Recorded Webcast
Credits
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 Participation
Social Determinants of Health: Collection, Integration, and Intervention
Education in the topic of social determinants of health is important to improve oncology care because a robust process of assessing need, integrating screening tools in the electronic health record, and connecting oncology patients with appropriate services is key to ensuring accessible and equitable cancer care.
Category
  • Best Practices
Format
  • Recorded Webcast
Credits
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 ASWB continuing education credit
  • 1.00 Participation

Pages